Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > NIH Weekly Funding Opportunities, Notices: December 22, 2017

NIH Weekly Funding Opportunities, Notices: December 22, 2017



 Notices

Requests for Applications
Program Announcements

     

  • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional)
    (PA-18-347)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional)
    (PA-18-348)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Self-Management for Health in Chronic Conditions (R01 Clinical Trial Optional)
    (PA-18-376)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional)
    (PA-18-377)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Community Partnerships to Advance Research (CPAR) (R21 Clinical Trial Optional)
    (PA-18-381)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Self-Management for Health in Chronic Conditions (R21 Clinical Trial Optional)
    (PA-18-384)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed)
    (PA-18-471)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Personalized Strategies to Manage Symptoms of Chronic Illness (R15 Clinical Trial Not Allowed)
    (PA-18-472)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed)
    (PA-18-473)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed)
    (PA-18-474)
    National Institute of Nursing Research
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed)
    (PA-18-475)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional)
    (PA-18-507)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first due date for this FOA is June 5, 2018 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional)
    (PA-18-508)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first due date for this FOA is June 16, 208 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)
    (PA-18-517)
    National Cancer Institute
    National Center for Advancing Translational Sciences
    National Center for Emerging and Zoonotic Infectious Diseases 
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Institute for Occupational Safety and Health
    Application Receipt Date(s): March 5, 2018, by 5:00 PM local time of applicant organization. 

     

  • Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
    (PA-18-525)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. 

     

  • Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
    (PA-18-529)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
    (PA-18-531)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date 

     

  • Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
    (PA-18-532)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional)
    (PA-18-545)
    National Institute on Aging
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Neurological Disorders and Stroke
    Office of Behavioral and Social Science Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trials Not Allowed)
    (PAR-18-505)
    National Institute of Mental Health
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional)
    (PAR-18-506)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional )
    (PAR-18-509)
    National Institute on Drug Abuse
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
    (PAR-18-510)
    National Institute on Drug Abuse
    Application Receipt Date(s): Standard dates apply ), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - Clinical Trial Optional)
    (PAR-18-511)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
    (PAR-18-512)
    National Institute on Aging
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
    (PAR-18-513)
    National Institute on Aging
    Application Receipt Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequently, standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
    (PAR-18-514)
    National Institute on Aging
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed)
    (PAR-18-516)
    National Institute on Aging
    Application Receipt Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequent due dates for new applications: June 8, 2018; October 9, 2018; February 8, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 7, 2020; and October 7, 2020, by 5:00 PM local time of the applicant organization. Due dates for resubmission and revision applications: July 9, 2018; November 7, 2018; March 7, 2019; July 7, 2019; November 7, 2019; March 7, 2020; July 7, 2020; and November 7, 2020 , by 5:00 PM local time of applicant organization 

     

  • Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed)
    (PAR-18-519)
    National Institute on Aging
    Application Receipt Date(s): New: March 26, 2018; June 6, 2018; October 7, 2018; February 7, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 8, 2020; and October 8, 2020, by 5:00 PM local time of the applicant organization. Resubmission/Revision: July 7, 2018; November 7, 2018; March 7, 2019; July 8, 2019; November 7, 2019; March 6, 2020; July 7, 2020; and November 6, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
    (PAR-18-521)
    National Eye Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
    (PAR-18-522)
    National Eye Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required)
    (PAR-18-523)
    National Eye Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed)
    (PAR-18-524)
    National Institute on Aging
    Application Receipt Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequently, standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
    (PAR-18-527)
    National Institute on Drug Abuse
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional)
    (PAR-18-528)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
    (PAR-18-530)
    National Cancer Institute
    National Institute of Biomedical Imaging and Bioengineering
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): The first due date for all types of applications allowed for this FOA is March 8, 2018. Thereafter Standard dates apply, by 5:00 PM local time of applicant organization, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional)
    (PAR-18-533)
    National Institute on Deafness and Other Communication Disorders
    Application Receipt Date(s): June 19, 2018; February 20, 2019; October 18, 2019; June 18, 2020; February 22, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)
    (PAR-18-534)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 15, 2018; August 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional)
    (PAR-18-538)
    National Institute on Aging
    Application Receipt Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequent due dates are June 20, 2018; February 20, 2019; June 20, 2019; February 20, 2020; and June 22, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed
    (PAR-18-539)
    John E. Fogarty International Center
    National Cancer Institute
    Application Receipt Date(s): March 7, 2018; March 7, 2019; March 6, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required
    (PAR-18-540)
    John E. Fogarty International Center
    National Cancer Institute
    Application Receipt Date(s): March 7, 2018; March 7, 2019; March 6, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional
    (PAR-18-541)
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Mental Health
    Application Receipt Date(s): February 7, 2018, August 9, 2018, February 9, 2019, August 9, 2019, February 11, 2020, by 5:00 PM local time of applicant organization. 

     

  • NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)
    (PAR-18-542)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, and July 20, 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional)
    (PAR-18-543)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, and July 20, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
    (PAR-18-544)
    National Institute on Aging
    Application Receipt Date(s): The first application due date is March 29, 2018, by 5:00 PM local time of the applicant organization. Subsequent due dates are June 8, 2018; February 8, 2019; June 8, 2019; February 7, 2020; and June 8, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates, including new, renewal, resubmission, and revision applications. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional
    (PAR-18-546)
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Mental Health
    Application Receipt Date(s): February 7, 2018, August 9, 2018, February 9, 2019, August 9, 2019, February 11, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required
    (PAR-18-547)
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): New applications - February 23, June 6, and October 4 of 2018; February 6, June 6 and October 8 of 2019; February 6, June 8, and October 6 of 2020 by 5:00 PM local time of applicant organization. Revised applications - July 6 and November 6 of 2018; March 6, July 8 and November 6 of 2019; March 6, July 7 and November 6 of 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
    (PAR-18-548)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): March 14, 2018; July 18, 2018; February 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5:00 PM local time of applicant organization. 

     

  • Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
    (PAR-18-549)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): March 14, 2018; July 18, 2018; February 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5:00 PM local time of applicant organization. 

     

  • Analytical Validation of Candidate Biomarkers for Neurological Disease (U01 Clinical Trial Optional)
    (PAR-18-550)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): March 14, 2018; July 18, 2018; February, 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed)
    (PAR-18-552)
    National Cancer Institute
    National Institute on Aging
    Application Receipt Date(s): June 8, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.